Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.

We developed a strategy to formulate supraparamagnetic iron oxides (SPIOs) in nanoparticles (NPs) of biodegradable copolymer made up of poly(lactic acid) (PLA) and d-alpha-tocopherol polyethylene glycol 1000 succinate (TPGS) for medical imaging by magnetic resonance imaging (MRI) of high contrast and low side effects. The IOs-loaded PLA-TPGS NPs (IOs-PNPs) were prepared by the single emulsion method and the nanoprecipitation method. Effects of the process parameters such as the emulsifier concentration, IOs loading in the nanoparticles, and the solvent to non-solvent ratio on the IOs distribution within the polymeric matrix were investigated and the formulation was then optimized. The transmission electron microscopy (TEM) showed direct visual evidence for the well dispersed distribution of the IOs within the NPs. We further investigated the biocompatibility and cellular uptake of the IOs-PNPs in vitro with MCF-7 breast cancer cells and NIH-3T3 mouse fibroblast in close comparison with the commercial IOs imaging agent Resovist. MRI imaging was further carried out to investigate the biodistribution of the IOs formulated in the IOs-PNPs, especially in the liver to understand the liver clearance process, which was also made in close comparison with Resovist. We found that the PLA-TPGS NPs formulation at the clinically approved dose of 0.8 mg Fe/kg could be cleared within 24 h in comparison with several weeks for Resovist. Xenograft tumor model MRI confirmed the advantages of the IOs-PNPs formulation versus Resovist through the enhanced permeation and retention (EPR) effect of the tumor vasculature.

[1]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[2]  Si-Shen Feng,et al.  Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. , 2006, Biomaterials.

[3]  Sung-chul Shin,et al.  Magnetic enhancement of iron oxide nanoparticles encapsulated with poly(d,l-latide-co-glycolide) , 2005 .

[4]  Catarina Pinto Reis,et al.  Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[5]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[6]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[7]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[8]  Peter R Seevinck,et al.  Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[9]  K. Landfester,et al.  Magnetic Polystyrene Nanoparticles with a High Magnetite Content Obtained by Miniemulsion Processes , 2003 .

[10]  S. Stainmesse,et al.  Formation and stabilization of a biodegradable polymeric colloidal suspension of nanoparticles , 1995 .

[11]  Chee Wee Gan,et al.  In Vitro and In Vivo Investigation on PLA–TPGS Nanoparticles for Controlled and Sustained Small Molecule Chemotherapy , 2008, Pharmaceutical Research.

[12]  H Cramer,et al.  Magnetic resonance imaging. Basic principles. , 1986, Minnesota medicine.

[13]  Yong Zhang,et al.  In‐vitro cytotoxicity, in‐vivo biodistribution and anti‐tumour effect of PEGylated liposomal topotecan , 2005, The Journal of pharmacy and pharmacology.

[14]  Atle Bjørnerud,et al.  Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging , 2004, Cell and Tissue Research.

[15]  H. Fessi,et al.  Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods , 2004, Pharmaceutical Research.

[16]  D. Mitchell,et al.  Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. , 1991, Radiology.

[17]  Robert Langer,et al.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.

[18]  D. C. Agrawal,et al.  Synthesis of iron oxide nanoparticles under oxidizing environment and their stabilization in aqueous and non-aqueous media , 2007 .

[19]  J. Ding,et al.  Synthesis of magnetite nanoparticles via a solvent-free thermal decomposition route , 2009 .

[20]  Y. Wang,et al.  Formulation of Superparamagnetic Iron Oxides by Nanoparticles of Biodegradable Polymers for Magnetic Resonance Imaging , 2008 .

[21]  I. Chen,et al.  Biomedical nanoparticle carriers with combined thermal and magnetic responses , 2009 .

[22]  Ralph Weissleder,et al.  Long-circulating iron oxides for MR imaging , 1995 .

[23]  D. Quintanar-Guerrero,et al.  A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique , 1997 .

[24]  P. Wust,et al.  Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. , 1993, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[25]  S. Feng,et al.  In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy. , 2007, Biomaterials.

[26]  T. A. Taton,et al.  Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. , 2005, Nano letters.

[27]  Hua Ai,et al.  Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. , 2009, Biomaterials.

[28]  K. Landfester,et al.  Fluorescent Superparamagnetic Polylactide Nanoparticles by Combination of Miniemulsion and Emulsion/Solvent Evaporation Techniques , 2009 .

[29]  K. Letchford,et al.  A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  S. Feng,et al.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[31]  P. Reimer,et al.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.

[32]  R Weissleder,et al.  Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.

[33]  Erkki Ruoslahti,et al.  Proteolytic actuation of nanoparticle self-assembly. , 2006, Angewandte Chemie.

[34]  K. Wormuth.  Superparamagnetic Latex via Inverse Emulsion Polymerization , 2001 .

[35]  K. Knížek,et al.  Magnetic poly(glycidyl methacrylate) microspheres containing maghemite prepared by emulsion polymerization , 2006 .

[36]  I. Chourpa,et al.  Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles. , 2005, International journal of pharmaceutics.

[37]  Hatem Fessi,et al.  Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique , 1996 .

[38]  K. Brindle,et al.  Assessing responses to cancer therapy using molecular imaging. , 2006, Biochimica et biophysica acta.